subsyndromes as different aspects of the same neurobiologic continuum, 4, 10, 11 whereas others consider them a heterogeneous cluster of separate entities. 7, 12 Long-term seizure outcome and possible need for lifelong AED treatment are highly relevant aspects of epilepsies that allow comparison of the different (sub)syndromes. With the use of appropriate AEDs, seizure remission can be achieved in 50-90% of GGE patients, [12] [13] [14] [15] but AED discontinuation has been reported to result in seizure relapses in 80% of cases. 16 The retrospective study presented here was designed to compare JAE, JME, and EGTCS with respect to long-term seizure outcome and need for ongoing AED treatment after a follow-up period of at least 20 years. Because GGE patients have been reported to display several neuropsychological and behavioral peculiarities, 17, 18 psychosocial aspects in terms of psychiatric comorbidity, academic education, and marital status were considered as well.
Methods

Patients
For this and previous studies, [19] [20] [21] an archive of 870 epilepsy patient records from 1955 to 2010 was examined. Most patients were diagnosed and treated for decades by the same senior epileptologist and co-author (DJ). He employed the diagnostic and classificatory tools available at the time, including the 1989 classification of the International League Against Epilepsy. 3 During review of the patient records, diagnoses were standardized according to the following criteria: Onset of absence epilepsy after the 11th birthday was categorized as JAE, whereas earlier onset was counted as CAE and not considered in this study. For subgroup and sensitivity analyses, JAE patients with nonpyknoleptic absence seizures (occurring less frequently than daily) were specifically evaluated. Nonpyknoleptic absence seizures are typical for JAE and therefore represent a narrower and more specific definition of this GGE subsyndrome. 5 Subjects with bilateral myoclonic seizures were classified as JME irrespective of eventual additional GTCS or absence seizures. 19, 20 In EGTCS, GTCS had to be the only seizure type. Depending on seizure occurrence in relation to the sleep-wake cycle, epilepsy with GTCS on awakening (EGTCS-A) could be distinguished from epilepsy with GTCS by random (EGTCS-R) with EGTCS-A representing the more traditional, narrower definition of EGTCS. 2, 3, 21 When the clinical phenotype was unequivocal, patients could be diagnosed without electroencephalography (EEG) studies, as would be requested by, for example, the 2013 consensus paper on JME. 22 
Procedures
Individual data were collected from the outpatient charts and from an additional survey in 2011 or 2012. At that time, all patients still alive and within reach were contacted for a postal questionnaire or a telephone interview regarding medical and psychosocial issues. Interviews for the specific GGE subsyndromes included questions on seizure outcome, use of AEDs, psychiatric comorbidity, marital status, and level of education. [19] [20] [21] Evidence of epilepsy in first-degree relatives (parents, siblings, or children) was defined as positive family history. Follow-up time was defined as the period between epilepsy onset (i.e., first recognized seizure) and last patient contact (questionnaire, interview, or last documented patient visit to outpatient clinic). Only subjects who had a follow-up of at least 20 years after epilepsy onset were included in this study. Epilepsy was considered resolved if a patient had been seizure-free for the last 10 years of follow-up and without AED for the last 5 years of follow-up. 23 Pharmacoresistance rates were not calculated because not all patients with seizures in the terminal 12 months had been treated verifiably with at least two AEDs. 24 GTCS outcome was analyzed separately because, first, GTCS is present in all GGE subsyndromes studied; second, GTCS is the most serious seizure type; third, compared to absence or myoclonic seizures, GTCS is least likely to be underrecognized and underreported by patients. The surveys were approved by the Charit e -Universit€ atsmedizin Berlin Institutional Review Board. Written informed consent was obtained from all subjects who completed an interview or questionnaire.
Statistical analysis
Statistical analysis was performed with SPSS Statistics 23.0 (IBM, Armonk, NY, U.S.A.). Interval type data are given as median and interquartile range (IQR). If ShapiroWilk test indicated normal distribution and Levene's test revealed homoscedasticity, groups were compared using one-way analysis of variance (ANOVA) as omnibus test and, if significant, Bonferroni-corrected two-tailed Student's t-test for post hoc analysis among the three groups. Otherwise Kruskal-Wallis ANOVA on ranks was performed as omnibus test, and Bonferroni corrected two-tailed Mann-Whitney U test was used for post hoc testing. Categorical data were analyzed using Pearson's two-tailed
Key Points
• Seizure and psychosocial outcome were analyzed in 176 patients with adolescent-onset generalized genetic epilepsy after 42 years of follow-up
• Five-year terminal seizure remission rate was 60%, with no significant differences between the epilepsy subsyndromes studied
• In 36% of patients, antiepileptic drugs have been withdrawn at least once; 52% had a seizure relapse, with higher rates in JAE than in JME
• Indicating favorable psychosocial outcome, 78% had married, 57% qualified for university entrance, and 23% reported psychiatric comorbidity Epilepsia, 58 (7) 
Results
Study population
Among the 870 reviewed patients, 343 had GGE. Of these, 167 were excluded from the study because of CAE, follow-up <20 years, or insufficient documentation of the data ( Fig. 1 ). In total, 176 outpatient cases (53 JAE, 66 JME, 57 EGTCS) were analyzed. Fifty-nine JME patients (89%) met the class I criterion of age at epilepsy onset between 10 and 25 years, and only three (5%) did not meet the class II criterion of age at epilepsy onset between 6 and 25 years (Fig. 1 ). 22 One hundred eight patients (61%; 31 JAE, 46 JME, 31 EGTCS) could be interviewed by telephone or by writing. 19, 21 Patients who completed the interview were significantly older at last contact, had longer follow-up and longer terminal seizure/GTCS remission; in addition, they were more likely to be AED-free at last contact and for the last 5 years, and to have resolved epilepsy. On the other hand, there were no significant differences regarding age at last seizure/GTCS or the other variables tested (data not shown). Fifteen of all patients had firstdegree relatives with epilepsy (9%; three JAE, five JME, seven EGTCS; Table 1 ). Except for one JAE patient who exclusively had absence seizures, all other 175 patients had a history of at least one GTCS. At epilepsy onset, EGTCS patients were significantly older (median age 18 years) than JAE and JME patients (14 years each; p ≤ 0.001; Table 1 and Fig. 2 ) and, subsequently, duration of follow-up was shorter in EGTCS patients (37 years) at least in comparison to JME patients (46.5 years; p ≤ 0.05). For the whole study population of 176 patients, median follow-up time was 42.5 years.
Seizure outcome
There were no significant differences between the groups regarding long-term seizure outcome (Table 1) . At the end of follow-up, 60% of all patients had been terminally seizure-free for at least 5 years. In all patients taken together, the last recognized seizure of any type occurred at a median age of 46 years (IQR 35-58 years) and the terminal seizure-free period lasted a median of 8 years (IQR 1-21 years). The median age at last GTCS was 43 years (IQR 33-57) and the respective terminal period without GTCS lasted 11 years (IQR 2-25). During the last year of follow-up, 11% of patients experienced GTCS and 20% still had seizures of any type. On the other hand, 19% of all patients were no longer taking any AEDs at the end of follow-up, and 14% had been off medication throughout at least the last 5 years. Except for one JME patient, all 14% had been seizure-free during the last 10 years of follow-up, which means that their epilepsy had resolved. 23 For 19 patients (one JAE, 17 JME, and one EGTCS), it was not possible to ascertain whether they had ever paused their AED medication (Table 1) . Among the remaining, 15 JAE patients (29%), 14 JME patients (29%), and 27 EGTCS patients (48%) had discontinued AED treatment temporarily or permanently. Median age at AED discontinuation was 38 years (IQR 27-47), and median duration of epilepsy at that time was 23 years (IQR 14.5-31.5). Seizure relapse rate after AED discontinuation was significantly lower in JME patients (21%) than in JAE patients (67%; p ≤ 0.05).
Exploratory subgroup, sensitivity, and multivariate analyses
In a subgroup analysis of JAE patients, epilepsy onset was significantly earlier in JAE patients with pyknoleptic absence seizures (JAE-p; median 12 years; n = 14) than in those with nonpyknoleptic absence seizures (JAE-np; narrow definition of JAE; median 15 years; n = 39). Beyond that, there was no significant difference between the two JAE subgroups regarding seizure and psychosocial outcome (Table S1 ). Another subgroup analysis was performed for EGTCS, which revealed no statistically significant difference between EGTCS-A (narrow definition, n = 42) and EGTCS-R patients (n = 15) apart from the sex ratio (31% vs. 60% females; Table S2), although there was a tendency toward worse seizure outcome in EGTCS-A.
For a sensitivity analysis, only patients who fulfilled the narrow definitions of JAE (JAE-np instead of all JAE) and EGTCS-A (instead of all EGTCS) were compared to JME patients. This did not change the results outlined above except that the three groups no longer differed significantly with respect to duration of follow-up (Table S3) .
After pooling all patient data, the variables sex, age at first seizure, age at last patient contact, and positive family history were tested in a multivariate analysis as possible independent predictors of favorable seizure outcome. Higher age at last contact tended to predict 5-year terminal remission of any seizure (176 cases included; OR 0.977; 95% CI 0.955-1.000; p = 0.054) and 5-year terminal remission of GTCS (175 cases included; OR 0.977; 95% CI 0.953-1.001; p = 0.055), but both results were statistically not significant.
Aspects of psychosocial outcome
Data on long-term psychosocial outcome could be obtained from about 70% of patients. There were no significant differences across all subsyndrome groups. Psychiatric comorbidity was documented for 23% of patients. Seventyeight percent of patients had married at least once, irrespective of eventual divorces, and 57% had reached an (40) 28 (65) 25 (61) n.s.
JAE, juvenile absence epilepsy; JME, juvenile myoclonic epilepsy; EGTCS, epilepsy with generalized tonic-clonic seizures alone; IQR, interquartile range; GTCS, generalized tonic-clonic seizure; AED, antiepileptic drug. a EGTCS differs significantly from JAE and from JME; p ≤ 0.001 each.
b JME differs significantly from EGTCS, p = 0.050. educational level of at least university entrance qualification (Table 1) .
Discussion
To every individual epilepsy patient, long-term outcome of his or her disease is of utmost interest. Until now, it has not been clear if JAE, JME, and EGTCS differ in long-term prognosis. This study is the first to compare outcome of adolescent-onset GGE subsyndromes after more than four decades of follow-up in a large, well-phenotyped patient population treated in the same epilepsy center.
The "single center" and "single doctor" approach used here has strengths and weaknesses. In general, it increases the internal validity of the data but reduces the external validity. All patients investigated here had been consulting a specialized adult care epileptologist, some of them for decades. By contrast, uncomplicated cases of GGE are usually treated by primary or secondary care physicians, or have already resolved in adulthood. Therefore, the patient population studied here most likely represents a selection of rather worse affected subjects. This assumption is supported by the fact that all subjects except for one JAE patient experienced GTCS, which has been reported to be associated with unfavorable long-term seizure outcome. 5, 6, 9, 25 On the other hand, continuous outpatient treatment by a single specialized epileptologist may have influenced the patients' outcome in a positive way.
Overall, the results obtained from this study are in line with the existing literature. Seizure onset in EGTCS has already been described to be about 2 years later than in JAE and JME. 11 Sex distribution in GGE patients is usually reported to be equal or to display a slight female preponderance. 5, 11, 13, 17, [25] [26] [27] The reasons for a male predominance among EGTCS and especially EGTCS-A patients in this study (Table S2 ) remain unclear.
The data presented in Table 1 and Figure 2 show hardly any difference between the three subsyndrome groups. The last seizure in an individual patient could occur at any age. Despite the presumably negative selection of patients, 60% achieved terminal 5-year remission after 42.5 years of follow-up. This falls within the scope of 15-68% terminal 6-or 5-year remission rates in JAE and JME that have been reported in five previous studies. 5, [25] [26] [27] [28] Interestingly, those remission rates were positively correlated with the respective average duration of disease of 18-39 years. Accordingly, in the current multivariate analysis depicted earlier, higher age at last patient contact tended to correlate with terminal 5-year seizure/GTCS remission. Although this finding was not statistically significant, it seems possible that stable seizure remission gradually becomes more likely with advancing age.
Long-term outcome did not differ between EGTCS-A and EGTCS-R, and not between JAE-np and JAE-p. However, seizure onset was earlier in JAE-p than in JAE-np, illustrating that the former may overlap with CAE.
When AEDs were discontinued, the relapse rate in JME patients was conspicuously low (21%) when compared to respective JAE and EGTCS patients (67% and 63%, respectively). This may at least partly be explained by comparably -although not significantly-higher age and longer duration of disease at time of AED discontinuation in JME patients. In addition, myoclonic seizures may be underreported at least in comparison to GTCS. One may also speculate that JME patients were more conservatively selected for AED discontinuation than respective JAE and EGTCS candidates were, bearing in mind the hitherto existing doctrine that JME required lifelong AED treatment. 7, 13, 29 However, these data must be interpreted carefully because they are incomplete: First, information is lacking for 17 JME (as well as for one JAE and one EGTCS) cases as to whether AEDs were ever discontinued. Second, only for 25 of all 48 Figure 2 . Individual JAE, JME, and EGTCS patients sorted for age at last seizure. Intervals between first and last seizure (red) and between last seizure and last patient contact (terminal seizure remission, blue) are given for each individual patient with JAE (left, n = 53), JME (middle, n = 66), and EGTCS (right, n = 57). Epilepsia ILAE Epilepsia, 58 (7):1244-1250, 2017 doi: 10.1111/epi.13761 patients who discontinued AED, the duration of the seizurefree period was documented beforehand (data not shown). With respect to the literature, reported seizure-relapse rates after AED discontinuation range from 19% to 68% in JAE, from 30% to 100% in JME, and from 18% to 80% in EGTCS patients. 9, 13, 27, 30 The heterogeneity of these findings is attributable to dissimilar proportions of patients to discontinue AEDs and to variable duration of epilepsy prior to AED discontinuation. EEG worsening after AED discontinuation and mixed seizure types including GTCS were described as independent predictors for seizure relapse in GGE. 9 In addition to occurrence of GTCS as described earlier, several factors have been reported to be associated with poor seizure outcome in GGE, for example, persistence of epileptiform EEG discharges despite AED treatment, 16 generalized paroxysmal fast EEG activity in absence epilepsy, 31 and manifestation of absence seizures and detection of photoparoxysmal EEG responses in JME. 19, 25, 26 As for EGTCS, occurrence of GTCS shortly after awakening (i.e., EGTCS-A) has been found to be associated with worse seizure outcome than random GTCS (EGTCS-R). 32 The data presented in the online-only supplement (Table S2) seem concordant, although not statistically significant. For all mentioned examples, the underlying pathomechanisms remain to be elucidated. Nevertheless, it seems possible to identify predictors for individual long-term seizure outcome across adolescent-onset GGE subgroup borders.
The debate as to what kind of epilepsy classification could be both pathophysiologically accurate and clinically useful is not limited to GGE subsyndromes. [4] [5] [6] [7] [8] 10, 11, 32, 33 Even the term "generalized" has recently been referred to as "inappropriate" and "no longer tenable" for epileptic seizures and syndromes in view of "bilateral networks of distributed and selective cortical and subcortical structures" in ictogenesis. 34 In 2010 and 2016, the ILAE Commission for Classification and Terminology repeatedly suggested to replace the former term "idiopathic generalized epilepsies" (IGEs) by "generalized genetic epilepsies" (GGEs). [1] [2] [3] Before then, the "idiopathic" generalized epilepsies had been "generally thought to be unaccompanied by other consequences or disabilities," 1 but neither mental health 11, 14, 17, 33 nor cognition, 11, 14, [35] [36] [37] nor neuroimaging, 31, 37, 38 of IGE/GGE patients proved to be actually normal.
Specific personality traits and subtle neuropsychological deficits have long been attributed particularly to subjects with JME, 20 but also to patients with CAE/JAE. 17, 36 Therefore, the three juvenile GGE subsyndrome groups were compared with respect to academic education, marital status, and psychiatric comorbidity. Although some tendencies toward a higher prevalence of psychiatric disorders in JME patients and toward less academic success in JAE patients became apparent, there were no significant differences (Table 1) . Because information on psychiatric comorbidity is based on the medical records and patients' self-reports, the validity of the data is limited. However, the findings are consistent with a meta-analysis on cognitive functioning 18 and with previous findings on specific personality traits in patients with GGE. 11, 14 Almost 60% of all patients achieved university entrance qualification (Table 1) , and approximately 30% were covered by private health insurance (data not shown). In the German population, both numbers are far above average. From the 1960s to 2010, the proportion of subjects with university entrance qualification within the general population in (West) Germany rose from below 10% to approximately 50%, 39 and <10% of citizens were covered by private health insurance. 40 Therefore, again, the patient cohort studied here is not representative of the general population. However, the findings indicate that long-lasting GGE can be compatible with high socioeconomic status if favorable framework conditions are provided.
To conclude, the data presented here demonstrate that long-term seizure outcome as well as aspects of psychosocial outcome in adolescent-onset GGE are highly similar within the ILAE-defined subsyndrome groups. 2, 3 Although the study cohort most likely represents a selection of rather worse affected subjects, 60% of patients became terminally seizure-free for at least 5 years, and in 14%, epilepsy even resolved. To confirm the current findings and, eventually, to gain more reliable long-term outcome data on adolescentonset GGE, prospective studies are needed.
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